Potential benefits of MOTS-c: Improved insulin sensitivity Better glucose control Increased exercise capacity Enhanced mitochondrial function Improved metabolic flexibility Unlike Semaglutide or Tirzepatide, MOTS-c does not primarily work by reducing appetite
This means a 1mg vial at 20mcg per dose (50 total doses) cannot be fully utilized unless the protocol runs at least 34 administrations per week
Fluid Retention And Congestive Heart Failure With Concomitant Use Of A PPAR Gamma Agonist Thiazolidinediones (TZDs), which are peroxisome proliferator activated receptor (PPAR) gamma agonists can cause dose related fluid retention, when used in combination with insulin
Changes in Blood Pressure Weight loss itself often leads to a natural reduction in blood pressure, which is generally a positive health outcome
Who should avoid using oral Semaglutide
This nutrient is pivotal for the transportation of long-chain fatty acids into the mitochondria, which are the powerhouses of cells, where they are oxidized and converted into energy